-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on Perspective Therapeutics, Lowers Price Target to $5

Benzinga·08/14/2026 18:18:09
Listen to the news
B of A Securities analyst Alec Stranahan maintains Perspective Therapeutics (AMEX:CATX) with a Neutral and lowers the price target from $6 to $5.